- Home
- AUID vs EPIX Comparison
AUID vs EPIX Comparison
Compare AUID & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUID
- EPIX
- Stock Information
- Founded
- AUID 2009
- EPIX 2009
- Country
- AUID United States
- EPIX Canada
- Employees
- AUID N/A
- EPIX N/A
- Industry
- AUID Computer Software: Prepackaged Software
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- AUID Technology
- EPIX Health Care
- Exchange
- AUID Nasdaq
- EPIX Nasdaq
- Market Cap
- AUID 74.1M
- EPIX 75.9M
- IPO Year
- AUID N/A
- EPIX N/A
- Fundamental
- Price
- AUID $5.42
- EPIX N/A
- Analyst Decision
- AUID
- EPIX Hold
- Analyst Count
- AUID 0
- EPIX 3
- Target Price
- AUID N/A
- EPIX $2.00
- AVG Volume (30 Days)
- AUID 125.5K
- EPIX 57.6K
- Earning Date
- AUID 08-07-2025
- EPIX 08-04-2025
- Dividend Yield
- AUID N/A
- EPIX N/A
- EPS Growth
- AUID N/A
- EPIX N/A
- EPS
- AUID N/A
- EPIX N/A
- Revenue
- AUID $1,025,363.00
- EPIX N/A
- Revenue This Year
- AUID N/A
- EPIX N/A
- Revenue Next Year
- AUID N/A
- EPIX N/A
- P/E Ratio
- AUID N/A
- EPIX N/A
- Revenue Growth
- AUID 230.96
- EPIX N/A
- 52 Week Low
- AUID $4.01
- EPIX $1.40
- 52 Week High
- AUID $10.95
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- AUID 51.91
- EPIX 50.49
- Support Level
- AUID $5.04
- EPIX $1.67
- Resistance Level
- AUID $6.14
- EPIX $1.73
- Average True Range (ATR)
- AUID 0.51
- EPIX 0.04
- MACD
- AUID 0.10
- EPIX -0.00
- Stochastic Oscillator
- AUID 61.07
- EPIX 55.56
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.